This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Stocks Under $3 With Upside

1. Novavax (NVAX) is a biopharmaceutical company focused on developing recombinant vaccines. The company's technology platform is based on virus-like particles (VLPs). The VLPs are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins.

Total revenue for the first quarter of 2011 surged to $834,000 from $110,000 in the year-ago quarter, primarily due to services performed under the HHS BARDA contract. For 2011, the company expects to generate revenue as it performs under the HHS BARDA contract. Net loss declined to $7.5 million or 7 cents per share from $10.3 million or 10 cents per share in the comparable quarter of 2010, impacted by lower research and development spending to support clinical trials for its H1N1 and seasonal influenza vaccine candidates in the three months ended March 31, 2011.

Cash and cash equivalents stood at $8.4 million, up 3.7% from $8.1 million at the end of Dec. 2010. Moreover, the company had a current ratio of 2.60.

All the four analysts covering the stock recommend a buy. There are no sell ratings on the stock. On average, analysts expect an upside of 197% to $7 in value from current levels.

>>To see these stocks in action, visit the 10 Stocks Under $3 With Upside portfolio on Stockpickr.
10 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BRD $0.00 0.00%
GLCH $1.50 0.00%
PURE $1.14 0.00%
ACPW $0.57 0.00%
CPST $1.67 -1.20%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs